The Pfizer-BioNTech vaccine has now been dubbed Comirnaty, which the company says represents a combination of the terms COVID-19, mRNA, community, and immunity.
The
It's the first time SpikeVax, until now known as the
During the interim order, the vaccines didn't go by their brand names, but now that new and more long-term data has been submitted and approved they will go by their permanent name.
Chief public health officer Dr.
"Unless we can quickly reduce overall transmission rates through accelerated vaccination and other measures where the virus is surging, continued expansion of the epidemic could lead to higher case counts than we have experienced thus far," Tam said at a news conference.
"We’re still close to seven million eligible people not yet fully vaccinated. Amid predominance of the highly contagious and more severe Delta variant, hospitalizations could exceed health care capacity in impacted areas."
The vaccines are even more important in the face of the highly contagious Delta variant, she warned.
The manufacturers hope full approval from the government agency will make people who still haven't received the shot more comfortable with the idea.
"Health Canada’s approval of Comirnaty for individuals ages 12 and older affirms the vaccine’s safety and efficacy shown in longer term data submitted to
Although the name change has been approved,
The FDA approved new names in
This report by
Note to readers: This is a corrected story. A previous version supplied an incorrect pronunciation for Comirnaty.
© 2021 The Canadian Press. All rights reserved., source